Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Servier’s EU Nightmare Continues As Commission Moves To Shut Down Disputed IP Practices

This article was originally published in The Pink Sheet Daily

Executive Summary

The European Commission’s allegations against Servier for alleged patent abuses could help to clarify the law in this area for original product manufacturers in the long term.

You may also be interested in...



EU Commission's Attack On Pharma Pay-For-Delay “Is Misguided”

The EU Commission's assumption that pharma pay-for-delay settlements are anti-competitive is by no means water-tight, a senior IP and competition lawyer suggests.

EU Commission Misses Chance To Offer Guidance On Patent Settlements

The European Commission has published its fourth report in monitoring patent settlements, but again has failed to offer pharma companies guidance on how to avoid potential competition abuses.

Lundbeck Blames EU Patent Enforcement Regimes For Generic Drug Agreements

The European Commission decides to fine Lundbeck and a number of generic drug manufacturers for conspiring to delay the entry of generic citalopram onto the market, but the final outcome of the case could not be decided for several years.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS074534

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel